GSK ends cough drug after phase III miss
GSK (NYSE:GSK) ended camlipixant development for chronic cough after CALM-2 missed its primary endpoint at 50mg.
GSK (NYSE:GSK) ended camlipixant development for chronic cough after CALM-2 missed its primary endpoint at 50mg.
Truist Financial (NYSE:TFC) reported Q2 2026 revenue of $5.23 billion and EPS of $1.08, matching profit expectations but narrowly missing revenue forecasts.
Fifth Third Bancorp (NYSE:FITB) reported Q2 2026 EPS of $0.83 and adjusted EPS of $1.02, supported by organic growth and Comerica integration.
South Plains Financial (NASDAQ:SPFI) reported Q2 net income of $19 million and diluted EPS of $0.96, supported by its BOH acquisition.
Autoliv (NYSE:ALV) reported Q2 net sales of $2.803 billion, up 3.3%, while diluted EPS fell 38% to $1.35.
Regions Financial (NYSE:RF) reported Q2 net income of $549 million and diluted EPS of $0.64, with adjusted earnings of $583 million and adjusted EPS of $0.68.
Netflix (NASDAQ:NFLX) shares fell 9.2% before Friday’s opening bell after its third-quarter revenue and earnings forecasts missed analyst estimates.
Honeywell Technologies (NASDAQ:HON) completed its £1.325 billion all-cash acquisition of Johnson Matthey’s Catalyst Technologies business.
Brent crude futures rose 0.08% to $84.30 as U.S.-Iran attacks threatened supplies through Hormuz and the Red Sea.
Cadeler (NYSE:CDLR) took delivery of Wind Ace, its 11th installation vessel, expanding its capacity for offshore wind projects.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy